-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MytT/C12F9XGkm50zdho+W/Xc9ViRTVbBwMLXEDhSvUD1kkd6XjnxvQxaialvloX EIVLyUyaKzYwg9r/wHvxAw== 0000950123-09-013812.txt : 20090731 0000950123-09-013812.hdr.sgml : 20090731 20090612180317 ACCESSION NUMBER: 0000950123-09-013812 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20090612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584526600 MAIL ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 CORRESP 1 filename1.htm corresp
(LA JOLLA PHARMACEUTICAL COMPANY LOGO)
June 12, 2009
VIA EDGAR CORRESPONDENCE
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
  Re:    La Jolla Pharmaceutical Company (the “Company”)
Acceleration Request for Registration Statement
Form S-3 (No. 333-158750)
Ladies and Gentlemen:
     Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effective date of the above-referenced registration statement be accelerated to Tuesday, June 16, 2009, at 4:00 p.m. (Eastern), or as soon thereafter as practicable.
     In making this acceleration request, the Company acknowledges that the acceleration of the effectiveness of the registration statement does not foreclose the Commission from taking subsequent action with respect to that filing and does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in such filing. Additionally, the Company acknowledges that it may not assert the Commission’s acceleration of the registration statement as a defense in any proceeding under the federal securities laws of the United States initiated by the Commission or any other person.
         
  Sincerely,
 
 
  /s/ Gail A. Sloan    
  Gail A. Sloan   
  Vice President of Finance and Secretary   
 
cc: NASDAQ (via facsimile)

GRAPHIC 2 a52688c2a5268802.gif GRAPHIC begin 644 a52688c2a5268802.gif M1TE&.#EAY@!``/<``)Z=GN+BXM[>WI*1DCDY.5Y>7LW,S8:%AO'P\-SCHZ$%!03$R,5!04.KJZM+1TNSL M['Y^?C8V-IB8F6E^[N[KFXN7IZ M>GAX>"TL+8"`@)J:FG9V=L_.S[*RLJ2DI*NJJJ*BHM74U>#@X*RLK*"@H)24 ME'1T=%I:6J>FIV-C8XN*BVAH:'Q\?-?6U[>VMSP[/(*"@EE866MJ:RXN+DQ, M3$Y.3JFHJ7)R8F/7T]?W\ M_?+R\MC7V/KY^OCX^'%Q</CX^[M[82#@]S;W*VMK:BGJ+JYN;&PL>SK[&=G M9^+AX5=75_3S\[BWN%Q<7$-#0_/R\K"OKV!?8/KY^6]O;_GX^).3DUM;6\O+ MRZ"?H-W=W?GX^2\O+_;U]H&!@=;5U:.BH_7U]+NZNJJIJ;&PL/?V]F)A89B7 MF/S[^_;U]2TM+4U-36EJ:3,S,^7EY3@X.,C'QT1$1+.SLRLK*^/DXS'A^OKZZJIJJ:EII:4E>;EYOCW^'5U=:RK MJWU]?:6EI=S;V]33U/OZ^K>WM]O:VE%14:>GIY66E<+"P<+!P9>7EW%R/($,BW+(P9+^3!%%^[(>/34F1 M_U0BE`GQ),I^(C!XFW%!X,N)/VE*+&D3Y,8K/S]VD1&'0QQ\KD+"40'C"TR! M9>Q!V.R5,BTR9H_M*F%79)UZ(16P8F12B@:9PX->8^/(3/:1Q" M>BWV.^&/1&",6=3Z.V-TDK]K::[^LW,MF^++_@P\/*EH41#,H-/60H(I[D,R MBK58!*-814@VM?R]LBHRL=HP'A>^0>MO@-#<_=B\>?(-M&:-&0P5"K61J>HE0+3=EK<'4\V_U"[#8%DGR<'];E\/&$9'9^9"YOVJ+F$ M)T415E>KNB)KM:Y]),XU:EE`4DC>+?91'9=Q,-U*C`BC6'L*=6'")Z!5@X%$_ MD938HT=`JD7A0%W0L,%E0PRBI$/];/%!D8I1D(%>^Z75'T7_I16@C?T,`-H+ M9T*4(&,9;;$>9L((@GBX*&EX@* MH%$P1J(.A?^943\@*":A6M+\)E*EF1E4!C.*99.,KAJ=!,AE**78-& M3!XE$G-:,104+\?U`E7'O@3LZ4*>.W>$LJ>+2!E7/^$HMH/$'=DLD!Z\I24# MS0EUP8-B8@A]):!9"I:"8MV4-+):/(!=T*(7#1.?I26Y08!BGLC__9#6_ZBB M6`5-@Y2(8B$`0Y#&\D9$[Y@SL)J6*%'%1,/@ISA-8\K]<*)8+"KU46H*+;`EP.MHE@M=+B. M4.JWIB4I3$PHQ@!!M*-M.U!KQ**8@P7Y0@L4DRS$`,Q3<+@,'P["!N2I90KN M.XC6,'&9PDE%,1M8W/7FE;VP$$8M%.B406BP+Q4D`&L,`=YF<``QO?2#%8I1 MPJN8%R2!'.(R=KC*X=12`>NMJ':I\I0%_Q33#A?B03%-\)L*'1(`?/DC&R=$ MR!CPE!9*1+`@6I/%9?1P%0:II1KXVZ#C.KB9&*S/7T)J`Y?2`@:YT6UB[%`, M$0[3CULHA@!^H*&:Y/(PM;SAB@1Q@&(NH<$?ZB^($EF#`]."J(3T8UIJ80;Z M)+)$1V)`,45@A$;\IY82`')<-8S)\]32BD_&!!^*Z8$/3P7$C@VE!HJ1@"6F M$X`0\`ULE4S(`A3##NDT!`@6XV)(4K>ZM.@")ENXA&(&$$9#8F]_FS'!W?P! M08UX3BUBP.4!:X(!6Z8E&X$X21G\,($)_($FB)B'8@[PR0HECT0Y!222TO;5O(/273I)_E[)B(?8H:] MJ24<@"C`-/VQ`2T(P04^(4;.1$C)\3T$I(A3##2:8`56<`$!^>G'H](RCG5A M9)'^,$5*#H!!Q>4&$EWS!PS,YDP.0K,A7^!J4K_XB47<@P9J*$H_,F!3AE+D MC0YQAD0QDP4([,F1'KC,_&8U!HRZH2`B"&L?#MHH/V!U`W_(F!@A\CB(F&"A ME^&&#M:`4(7$I%UJZ8/)'DJ0@5VF%N5(`PK[003%2`)K/>J'%],2C:3_%.HR M$7"#W!9B@APIIA55:J8^9E(%J**::$2&M0+80#IP(,GPH9I%@)6#UV(&C0%`U\.I0,8=<%A MNN"8)MRB?05)PQ7^B3$A!6*G!*@"&NE$BG'$+RT24("5RCK&LPH)#&&M@`>6 M%Y:HD:*Z051#U(';ZK@_QNK\(8V@#$+WW9R.N#`:EJR M8(-#T#$`YUBC6H[@9SZ1N"$F3@@N$">%`_&/6VGA173M9X%*6_K2%E"'H)FQ M8$\9P%T,Z<<^FF.U24(T`Q\#S3ST$0,,5`(-IN`##%`P8QY/.&QL-2;Q@KSC MXPBS,4;&8/-Y:V066$BZTI?.=$&\(!Y0-T`$^V$*J%M=Q,4BRH$YKBYP($$# MM)"`$T6Q"5R@0A6)B,E^J<'TMKL="]0HR"G>3O>EMV'J(U"Z(#1A"87Y_>^> M/4DNZ/`JF0/^\(A/O.+'M/C&._[QD(^\Y"=/^A'3_K2F_[TJ$^]ZE?/^M:[/O(R"8I<+=S9E,A%]DOZ#80-S^7>T<>O+/#O[WMB\][M2,?/;8-=3^X0'TX1$8N"?!03`)P?8((`*HI,07_ M];D@4KFDX0WFB0DI!J'>@B1@&;:]@"9"D4>YG&+\U&>#3]1P]YC8`AUY@W]< M(`\O80JX1A!KX`&4<`;#!PP6%!,"8&H(,0>00`G=I1#'$`DQ``SYQ@B,0!2I MX&<#H0#C!WYLH@"5D!0*0$\"40DF@%"D$'<",0>!\(`'$0(1,`GJ<`G>0!#3 M$"X"H06#)1!O(`P%1!`Y\`J3,`D-\`U$)0#^T`((M0(A$``%P0?0\&($\06` M8`16T`V7@`TO00C7(`DX<(8B,!!Y4``#$0D],!#`<(:;T`LXH`X+5@!0(!=$ MP@Z`\`H+L`LI,0./8&9S(P=TD@"7D`*`T`"OH'_3_^4$EW``-X`+WQ!0/K$# M__4/L!`"Q$`0>!`+DX`"2P`!+S%%#$`3>%`-*?@/*6!@-K0)@=`%7P`"L;!D M"1$";1`3((`'/A@N"R&$*:$+S4`X!9$#)!`37<``/2@0`G`)%'!8:1`+09"+ M`+/X$'WS`$G-6*DP$$?0`:0`G!0"#M`*CDP!#WP"I?0.@-QE'"`"S]2#$Y)$(2` M"ER@#POP$OE`DWJ@@#`0A)@!)NP`U?0@CC MV(X"80!&@%#8D`0&@9T$<98"H0@J`%4GT0W1*1!L0``P.@D$,*+]B$;$@@DJ M0$\G,0"JH(;8R#.:<#4.^0&=0`AX@`'UL)]X\#4\V@^HT`!+:`3-\!)X``)? MP`2;D`28F1*9@`04^I0&\8,#D:VW_\`4\@`(AF@<#_[$)$W"B_;`(%(`H M+-H/-<`,"*4!XS`0F,`-`"`"<-`#G""<.^`+'7"J6/?"C%0D"_[`%`U`! M>TH0?5H3$;!Q*=$"BK`0B-`-A^`3,``*);$'/D`45M`()0$!'>`3$\`)_4`' M$0`6*$`./K$('E`2&"`$!%$)/C`/O6`,7](/HQ`!(`NRTC80@Q`!W-"90+@+1!39P#S\Q!R1`"'*Q`OWW#S;`J/\P!BG@ M`$%1!9!0$[O')+&WGEJWGK?')`H15;A'$[`E,;J7$C=AM[FG=HS;N([[N)`;N9)[>`$!`#L_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----